• 

  Alzheimer’s Drug Decision Pushed: FDA Slows Down on Donanemab
• 

  Leading Neurologist: This Gene Raises Your Risk of Alzheimer’s—and Drug Side Effects
• 

  Alzheimer’s Drugs and ARIA: Leqembi ‘Brain Bleeds’ Side Effect, Explained
• 

  Neurologists Warn: Galantamine Brain Supplements Contaminated With Bacteria
• 

  Viagra May Cut Dementia Risk—But Don’t Get Too Excited
• 

  No More Aduhelm: Biogen Halts Sales of Alzheimer’s Drug
• 

  Bill Sasse: An Insider’s Account of the Alzheimer’s Solanezumab Drug Trial
• 

  FAQ: What Is Alzheimer’s Drug Leqembi, Where Is It Approved, and More
• 

  VIDEO: The Biggest Alzheimer’s Research Breakthroughs Last Year
• 

  Designing Alzheimer’s Drugs to Conduct the Immune System’s Orchestra
• 

  Leaked Investigation Into Cassava Alzheimer’s Drug Data Now on Pause
• 

  CTAD: T3D’s Experimental Alzheimer’s Pill Is Insulin for the Brain
• 

  OP-ED: New Alzheimer’s Drugs Don’t Deserve the Hype
• 

  Xanax and Dementia: Doctors Weigh In on Safety of Benzodiazepines
• 

  Your Guide to FDA-Approved Alzheimer’s Drugs

Previous678Next